November 16, 2011
Former Walgreens Executive & Healthcare Veteran Stanley B. Blaylock Joins SoloHealth Board
ATLANTA, GA, November 16, 2011 /24-7PressRelease/ -- SoloHealth, a consumer-driven healthcare technology company, announced today that Stanley B. Blaylock, former president of Walgreens Health Services and Senior Vice President of the Walgreen Company, will join SoloHealth's board of directors, effective immediately.
Blaylock has more than 20 years of experience that includes wide-ranging successes in the fields of healthcare, entrepreneurship, and investment banking. The announcement comes as SoloHealth prepares for a nationwide rollout in 2012 of its next-generation, consumer health screening kiosk, the SoloHealth Station.
"We are excited and honored that such a respected figure in the healthcare community has agreed to join the SoloHealth board, especially as we ready ourselves for what promises to be a fast-growing and pivotal next 12-18 months for the company," said Bart Foster, founder and CEO of SoloHealth. "Stan brings unparalleled finance, entrepreneurial, and healthcare knowledge to SoloHealth and will provide invaluable counsel during this exciting time of growth as we roll out our new healthcare solution nationwide."
Blaylock began his career in healthcare investment banking, where he rose to the position of global co-head of health care investment banking at Deutsche Bank. In this capacity, he oversaw the execution of 149 financings for approximately $45 billion and 54 mergers and acquisitions of approximately $24 billion.
Blaylock went on to co-found specialty pharmacy solutions company Medmark, where he served as executive vice president/CFO and chief administrative officer until his promotion to president and CEO in 2005.
When Walgreens acquired Medmark in 2006, Blaylock joined the company, and through a series of quick promotions, became Walgreens Senior Vice President and President of Walgreens Health Services. During his approximately four years at Walgreens, he successfully integrated Medmark, driving Walgreens Specialty Pharmacy to the #3 player in the industry through rapid internal growth and key strategic acquisitions. He was responsible for enhancing more than 7,100 community-based pharmacies and managed approximately 7,000 Walgreens employees with P&L responsibility for approximately $4 billion in revenues.
Blaylock currently serves on the Board of Directors of NovaSom, Inc., a leading provider of home sleep testing services for obstructive sleep apnea.
He is also a member of the Board of Directors of MTS Medication Technologies, an international provider of adherence packaging systems, designed to improve medication dispensing and administration. He earned a degree in economics and communication studies from the University of Virginia and received his master's degree in business administration from Harvard Business School. He is also a 2009 fellow of the CEO Perspective Program from Northwestern's Kellogg School of Management and Corporate Leadership Center.
About SoloHealth: Based in Atlanta, Ga., SoloHealth is the leader in self-service healthcare, utilizing technology to develop and deploy interactive health screening kiosks, as well as other platforms, in an effort to empower consumers about their health through awareness, education and action. The award-winning company's first offering was the EyeSite Vision kiosk, currently located in retail outlets in select national markets. In summer 2010, the company received a $1.2 M grant from the National Institute of Health (NIH), a division of the U.S. Department of Health and Human Services, to help enable innovation for self-service healthcare and prevention. In 2011, SoloHealth announced its next-generation kiosk, the SoloHealth Station, offering vision, blood pressure, weight, and body mass index; receive an overall health assessment; and access a database of local doctors. The company's bilingual kiosks provide free health screenings and recommendations for follow-up care, which leads to prevention and lower health care costs. For more information, visit www.solohealth.com.
Read more: http://www.digitaljournal.com/pr/492302#ixzz1duZU8JNlPosted by staff at November 16, 2011 03:49 PM